| Website | directflowmedical... |
| Category | BioTech |
| Phone | 707-576-0420 |
| Employees |
| Series C, 10/09 Johnson & Johnson Development Foundation Medical Partners VantagePoint Venture Partners DFJ ePlanet Ventures EDF Ventures New Leaf Venture Partners Spray Venture Partners | $40M |
Direct Flow Medical is a medical device company developing a percutaneous aortic tissue valve prosthesis to provide patients requiring treatment of cardiac valve insufficiency with a safe and effective percutaneous option. Approximately 1.2 million people over the age of 65 have calcified aortic valves, yet only an estimated 150,000 are surgically treated each year.
